Evidence map›Paper›PMID 35937017›Full record

ArticleClinical case reports2022

COVID-19-associated mucormycosis involving the maxilla.

Mahboube Hasheminasab, Mojtaba Salehi Karizmeh, Reza Sharifi, Majid Beshkar, Narges Matloubi, Amir Ali Asadi, Elham Nazar

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mahboube HasheminasabDepartment of Oral and Maxillofacial Surgery and Craniomaxillofacial Research Center, Faculty of Dentistry Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0001-7815-7866
Mojtaba Salehi KarizmehDepartment of Oral and Maxillofacial Surgery and Craniomaxillofacial Research Center, Faculty of Dentistry Tehran University of Medical Sciences Tehran Iran.
Reza SharifiDepartment of Oral and Maxillofacial Surgery and Craniomaxillofacial Research Center, Faculty of Dentistry Tehran University of Medical Sciences Tehran Iran.
Majid BeshkarDepartment of Oral and Maxillofacial Surgery and Craniomaxillofacial Research Center, Faculty of Dentistry Tehran University of Medical Sciences Tehran Iran.
Narges MatloubiDepartment of Oral and Maxillofacial Surgery and Craniomaxillofacial Research Center, Faculty of Dentistry Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-1427-7305
Amir Ali AsadiDepartment of Oral and Maxillofacial Surgery and Craniomaxillofacial Research Center, Faculty of Dentistry Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0003-0206-4676
Elham NazarDepartment of Pathology Sina Hospital, Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0001-5228-1981
Tehran University of Medical Sciences · IRSina Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is important to increase the awareness and knowledge of head and neck surgeons about the recent surge of craniofacial mucormycosis in COVID-19 patients because early diagnosis and appropriate treatment are essential to improve the outcomes. Here, we describe clinical features, treatment protocols, and outcomes of treatment in eight patients with COVID-19-associated mucormycosis in the maxilla. Consistent with the findings of previous studies, our experience in the management of these eight patients shows that early administration of amphotericin B and prompt aggressive surgery are essential for optimal control of the disease.

Indexed as

COVID‐19maxillaMucormycosispandemic

Identifiers

PMID35937017
PMCPMC9347695
OpenAlexW4289596352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.